<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equations.</p
<p>Incidence and hazard ratio of outcome variables associated with premotor symptoms in Cox's regres...
The NOAC and warfarin groups both showed a lower cumulative risk of efficacy outcomes compared with ...
<p>Cumulative incidence in quartiles of Tau-A and Tau-C as a function of follow-up time. Left panel ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
Cumulative incidence rates for all-cause death/myocardial infarction in overall (A) and matched (B) ...
<p>Cumulative incidence curves applied in the testing set to assess the competing mortality risks in...
(A) Simulated daily incidence. (B) Simulated daily prevalence based on the convolution of incidence ...
Note that different levels of δ are depicted column-wise, while different extended SIR models are de...
Cumulative incidence curves showing the probability of initiating treatment for low-risk patients (g...
<p>Cumulative incidence of incident respiratory failure in the different subgroups.</p
<p>The estimated cumulative incidences of all-cause death (A), MI (B), ST (C), TVR (D) and MACE (E) ...
<p>Incidence and hazard ratio of outcome variables associated with premotor symptoms in Cox's regres...
The NOAC and warfarin groups both showed a lower cumulative risk of efficacy outcomes compared with ...
<p>Cumulative incidence in quartiles of Tau-A and Tau-C as a function of follow-up time. Left panel ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
Cumulative incidence rates for all-cause death/myocardial infarction in overall (A) and matched (B) ...
<p>Cumulative incidence curves applied in the testing set to assess the competing mortality risks in...
(A) Simulated daily incidence. (B) Simulated daily prevalence based on the convolution of incidence ...
Note that different levels of δ are depicted column-wise, while different extended SIR models are de...
Cumulative incidence curves showing the probability of initiating treatment for low-risk patients (g...
<p>Cumulative incidence of incident respiratory failure in the different subgroups.</p
<p>The estimated cumulative incidences of all-cause death (A), MI (B), ST (C), TVR (D) and MACE (E) ...
<p>Incidence and hazard ratio of outcome variables associated with premotor symptoms in Cox's regres...
The NOAC and warfarin groups both showed a lower cumulative risk of efficacy outcomes compared with ...
<p>Cumulative incidence in quartiles of Tau-A and Tau-C as a function of follow-up time. Left panel ...
DOI
Add to ORKG